𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis

✍ Scribed by George P. Browman; D. Ian Hodson; Robert J. Mackenzie; Nancy Bestic; Lisa Zuraw

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
154 KB
Volume
23
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

A systematic review was conducted to develop clinical recommendations for concomitant chemotherapy (CT) and radiotherapy (RT) in patients with locally advanced squamous cell head and neck cancer (SCHNC).

Methods

Results of published randomized controlled trials (RCTs) were pooled using Meta‐analyst^0.988^ software.

Results

A pooled analysis of 18 RCTs (20 comparisons) involving 3,192 patients detected a reduction in mortality for concomitant therapy compared with RT alone (odds ratio [OR], 0.62; 95% confidence interval [CI], 0.52–0.74; relative risk, 0.83; risk reduction, 11%; p < .00001). Platinum‐based regimens involving 1,514 patients from nine trials (10 comparisons) were most effective (OR, 0.57; 95% CI, 0.46–0.71; p < .00001; risk reduction, 12%). Concomitant therapy produced more acute adverse effects than RT alone.

Conclusion

Platinum‐based concomitant CT and RT is superior to conventional RT alone in improving survival in locally advanced SCHNC. Subgroup analyses can be used to help in choosing the most appropriate concomitant regimen. Β© 2001 John Wiley & Sons, Inc. Head Neck 23: 579–589, 2001.

πŸ“œ SIMILAR VOLUMES

Postoperative chemoradiotherapy for adva
Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: A systematic review with meta-analysis
✍ Eric Winquist; Tom Oliver; Ralph Gilbert πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 272 KB πŸ‘ 1 views

## Abstract ## Background. This systematic review evaluates the use of postoperative chemoradiotherapy for patients with advanced (stage III or IV) squamous cell carcinoma of the head and neck at a high risk of recurrence. ## Methods. The literature was systematically searched for eligible rando

Pilot trial of concomitant chemotherapy
Pilot trial of concomitant chemotherapy with paclitaxel and split-course radiotherapy for very advanced squamous cell carcinoma of head and neck
✍ Olavo Feher; Sandro J. Martins; Candice A. Lima; JoΓ£o V. Salvajoli; Andrew J. Si πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 2 views

## Abstract ## Purpose The combination of chemotherapy and irradiation is considered the standard of care for the treatment of advanced squamous cell carcinoma of head and neck (SCCHN). Paclitaxel has shown a single‐agent activity in SCCHN. Besides, this drug is a promising radiosensitizer for som

Management of the neck in a randomized t
Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer
✍ Pierre Lavertu; David J. Adelstein; Jerrold P. Saxton; Michelle Secic; John R. W πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

Background. Treating the neck after organpreservation treatment with radiotherapy or chemoradiotherapy can be problematic. Methods. To develop management guidelines, we reviewed the results of a 100-patient phase-3 trial that had compared outcome after radiotherapy alone with outcome after chemorad